Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About Ulcerative Colitis
Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the colon and rectum. Inflammation and ulcers are formed in the innermost lining of the colon and rectum, resulting in the production of pus and mucous. Based on the extent of inflammation and the location, ulcerative colitis can be of different types: ulcerative proctitis, proctosigmoiditis, left-sided colitis, pancolitis or universal colitis, and fulminant colitis. Abdominal cramps, diarrhea, and rectal bleeding are among the common symptoms observed in individuals with the disease. Medications such as 5-aminosalicylates, steroids, purine analogs, immunomodulators, and biologics are used to treat the disease.
Technavio’s analysts forecast the global ulcerative colitis market to grow at a CAGR of 6.6% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global ulcerative colitis market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used to treat ulcerative colitis.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Ulcerative Colitis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AbbVie
• Janssen Biotech
• Merck
• Takeda Pharmaceuticals
Other prominent vendors
• Abbott
• Ajinomoto Pharmaceuticals
• Amgen
• Arena Pharmaceuticals
• AstraZeneca
• Astellas Pharma
• Avaxia Biologics
• BioLineRx
• Celgene
• Cosmo Pharmaceuticals
• Eisai
• Ferring Pharmaceuticals
• Galapagos
• Genentech
• Gilead Sciences
• GlaxoSmithKline
• Hutchison Medi Pharma
• Immune Pharmaceuticals
• InDex Pharmaceuticals
• Kaken Pharmaceutical
• Kissei Pharmaceutical
• Kyowa Hakko Kirin
• Lipid Therapeutics
• Meda
• Mitsubishi Tanabe
• Mochida Pharmaceutical
• Morphotek
• Nestlé
• Pfizer
• Procter & Gamble
• Qu Biologics
• Receptos
• Salix Pharmaceuticals
• Shield Therapeutics
• Shire Pharmaceuticals
• Sterna Biologicals
• Tillotts Pharma
• TopiVert
• UCB
• Zeria Pharmaceutical
Market driver
• Increase in patient assistance programs
• For a full, detailed list, view our report
Market challenge
• Patent expiries
• For a full, detailed list, view our report
Market trend
• Rising use of biologics
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the colon and rectum. Inflammation and ulcers are formed in the innermost lining of the colon and rectum, resulting in the production of pus and mucous. Based on the extent of inflammation and the location, ulcerative colitis can be of different types: ulcerative proctitis, proctosigmoiditis, left-sided colitis, pancolitis or universal colitis, and fulminant colitis. Abdominal cramps, diarrhea, and rectal bleeding are among the common symptoms observed in individuals with the disease. Medications such as 5-aminosalicylates, steroids, purine analogs, immunomodulators, and biologics are used to treat the disease.
Technavio’s analysts forecast the global ulcerative colitis market to grow at a CAGR of 6.6% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global ulcerative colitis market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used to treat ulcerative colitis.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Ulcerative Colitis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AbbVie
• Janssen Biotech
• Merck
• Takeda Pharmaceuticals
Other prominent vendors
• Abbott
• Ajinomoto Pharmaceuticals
• Amgen
• Arena Pharmaceuticals
• AstraZeneca
• Astellas Pharma
• Avaxia Biologics
• BioLineRx
• Celgene
• Cosmo Pharmaceuticals
• Eisai
• Ferring Pharmaceuticals
• Galapagos
• Genentech
• Gilead Sciences
• GlaxoSmithKline
• Hutchison Medi Pharma
• Immune Pharmaceuticals
• InDex Pharmaceuticals
• Kaken Pharmaceutical
• Kissei Pharmaceutical
• Kyowa Hakko Kirin
• Lipid Therapeutics
• Meda
• Mitsubishi Tanabe
• Mochida Pharmaceutical
• Morphotek
• Nestlé
• Pfizer
• Procter & Gamble
• Qu Biologics
• Receptos
• Salix Pharmaceuticals
• Shield Therapeutics
• Shire Pharmaceuticals
• Sterna Biologicals
• Tillotts Pharma
• TopiVert
• UCB
• Zeria Pharmaceutical
Market driver
• Increase in patient assistance programs
• For a full, detailed list, view our report
Market challenge
• Patent expiries
• For a full, detailed list, view our report
Market trend
• Rising use of biologics
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
